Home LiteratureArticle Details
PMID: 2720648 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Identification and characterization of X-ray-induced proteins in human cells.

Cancer research ·Vol. 49 ·No. 11 ·1989-06-01 ·Pages 2871-8

Boothman DA, Bouvard I, Hughes EN

Abstract

In order to investigate the biochemical events involved in potentially lethal DNA damage repair (PLDR), we have identified a pleiotropic protein expression response that is activated upon X-irradiation of confluence-arrested human malignant melanoma (U1-Mel) cells. Plateau-phase U1-Mel cells were selected because of their extraordinary capacity for PLDR. Eight major X-ray-induced polypeptides (XIPs) of Mr 126,000-275,000 (i.e., XIP126 through XIP275) were detected by resolving L-[35S]methionine-labeled whole cell extracts using two-dimensional gel electrophoresis. XIPs were found in unirradiated, proliferating U1-Mel cells, shut off under plateau-phase conditions and resynthesized in response to X-irradiation. The expression of three classes of proteins was affected by X-irradiation. Class I proteins, XIP145 and XIP269, were induced linearly with increasing X-ray doses. The rate of synthesis of class II proteins, XIP126, XIP135, XIP138, XIP141, XIP147, and XIP275, increased linearly with low X-irradiation doses, but plateaued at doses of 150-250 cGy. In contrast, the expression of class III proteins, 47,000 and 254,000 Mr proteins, decreased with increasing X-ray doses. Tumor, cancer-prone, and normal human cells, which represent a wide range of cells with varied repair capacities, were investigated to better understand the role of XIPs in DNA damage responses. X-irradiated normal and tumor cells induced the synthesis of XIP145 and XIP269. A strong correlation between the induction of XIP269 and PLDR capacity, as measured by delayed plating of plateau-phase cells, was noted. XIP269 was present in six of seven normal and tumor cells types, but was completely absent in cells from patients with Bloom's syndrome and ataxia telangiectasia. X-irradiated Fanconi's anemia and xeroderma pigmentosum cells synthesized low levels of XIP269. The majority of XIPs synthesized by X-irradiated cells from cancer-prone patients were of low molecular weights. A number of XIP expression characteristics suggest their role in either gross chromosomal PLDR and/or in X-ray adaptivity responses: (a) XIP expression was inhibited by 1 microgram/ml cycloheximide, a dose which decreased survival 6-fold during PLDR holding and resulted in greater than 80% inhibition of protein synthesis; (b) XIP expression was specific for ionizing radiation damage, since heat shock, hypoxia, and alkylating agents failed to induce their synthesis; (c) the time course of expression was long, with the first appearance of XIPs at 3 h and maximal expression at 4 h.

MeSH Terms
Carcinoma/genetics DNA Repair DNA, Neoplasm/radiation effects Dose-Response Relationship, Radiation Electrophoresis, Gel, Two-Dimensional Fibrosarcoma/genetics Humans Laryngeal Neoplasms/genetics Lung Neoplasms/genetics Melanoma, Experimental/genetics Molecular Weight Neoplasm Proteins/metabolism SOS Response, Genetics
Chemicals
DNA, Neoplasm Neoplasm Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Boothman D A
Division of Cell Growth and Regulation, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Bouvard I
Hughes E N
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1989-06-01
Pages
2871-8
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · 5T32 CA 09361 · United States
NCI NIH HHS · CA 22427 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com